- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Leonhart Gets a Pass
On Wednesday, November 17, the Senate Judiciary Committee convened for the nomination hearing of Michele Leonhart for the position of Administrator of the Drug Enforcement Agency (DEA). In preparation, ASA had submitted questions for the committee members to ask Ms. Leonhart, hoping that she would finally be taken to task for ignoring statements issued by the President, Attorney General, and Assistant Attorney General regarding ceasing raids on medical marijuana dispensaries. As both Deputy Administrator and Administrator, Ms. Leonhart has been behind an extremely large number of these paramilitary type raids on dispensaries, and ASA implored committee members to ask her why these raids were continuing, why she was continuing to prosecute those who were "in clear and unambiguous compliance with state law."
Instead, Ms. Leonhart was praised for her work. Senators Franken and Klobuchar were both proud to claim the native Minnesotan as one of their own and Senator Feinstein was pleased to note that Ms. Leonhart and her family currently reside in California. The only real questioning on marijuana came that afternoon from Senator Jeff Sessions of Georgia (seemingly the only Republican Senator present and definitely the only one who asked any questions of Ms. Leonhart), and that was in regard to legalization. Senator Sessions believes legalizing is dangerous and the wrong thing to do and praised Ms. Leonhart agreed with him. This led to Ms. Leonhart's only comment of the day that was truly pertinent to medical marijuana when she said that she and the DEA would continue to enforce federal drug laws regardless of state law. It looks like we can expect more of the same old from the DEA in the near future.
Share